CJC-1295 vs Tesamorelin
Research material comparison: compound class, molecular data, purity standards, available formats and batch COA documentation. For in vitro research use only.
| Attribute | CJC-1295 | Tesamorelin |
|---|---|---|
| Compound Class | GHRH analogue (GHRH receptor agonist) | GHRH analogue (GHRH receptor agonist) |
| Sequence | Not stated | Trans-3-hexenoic acid-GHRH(1-44)-NH2 (44-amino acid modified GHRH) |
| Molecular Weight | No DAC: ~3367.9 g/mol; With DAC: ~3647.3 g/mol | ~5135.9 g/mol |
Research Material Specifications
Catalog specifications for the corresponding research materials, including batch documentation coverage.
| Specification | CJC-1295 | Tesamorelin |
|---|---|---|
| Purity Standard | >99% | >99% |
| CAS Number | Ipamorelin: 170851-70-4; CJC-1295: not on file | 218949-48-5 |
| Molecular Formula | Ipamorelin: C₃₈H₄₉N₉O₅; CJC-1295: not on file | C₂₂₃H₃₇₀N₇₂O₆₉S |
| Available Formats | 10mg, 5mg, 10mg | 10mg, 20mg, 10mg, 20mg |
| Batch COAs Published | 1 on file | 1 on file |
| Stock Status | In stock | In stock |
In the compound library
Availability at Volta Peptides
Research use only. For in-vitro laboratory research by qualified professionals only. Not for human or animal administration. Not a drug, food, cosmetic or dietary supplement. Not intended to diagnose, treat, cure, mitigate or prevent any disease. Volta does not provide dosing, administration or protocol guidance for any material listed.
More on Tesamorelin
Everything Volta publishes on a compound, the measured batch figures, the certificates, the handling notes and every vial size, is collected on one page per compound.
Explore More
Comparisons
Compare any two peptides side-by-side or browse our curated popular matchups.
